<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martz SL</submitter><funding>SEAMO</funding><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><pagination>452-465</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5177537</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>52(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>A defined Microbial Ecosystem Therapeutic (MET-1, or "RePOOPulate") derived from the feces of a healthy volunteer can cure recurrent C. difficile infection (rCDI) in humans. The mechanisms of action whereby healthy microbiota protect against rCDI remain unclear. Since C. difficile toxins are largely responsible for the disease pathology of CDI, we hypothesized that MET-1 exerts its protective effects by inhibiting the effects of these toxins on the host.&lt;h4>Methods&lt;/h4>A combination of in vivo (antibiotic-associated mouse model of C. difficile colitis, mouse ileal loop model) and in vitro models (FITC-phalloidin staining, F actin Western blots and apoptosis assay in Caco2 cells, transepithelial electrical resistance measurements in T84 cells) were employed.&lt;h4>Results&lt;/h</pubmed_abstract><journal>Journal of gastroenterology</journal><pubmed_title>A human gut ecosystem protects against C. difficile disease by targeting TcdA.</pubmed_title><pmcid>PMC5177537</pmcid><funding_grant_id>R01 DK105118</funding_grant_id><funding_grant_id>R33 AI121575</funding_grant_id><funding_grant_id>R21AI121575</funding_grant_id><funding_grant_id>R21 AI121575</funding_grant_id><pubmed_authors>Gloor GB</pubmed_authors><pubmed_authors>Weese S</pubmed_authors><pubmed_authors>Claud EC</pubmed_authors><pubmed_authors>Noordhof C</pubmed_authors><pubmed_authors>He SM</pubmed_authors><pubmed_authors>Carlucci C</pubmed_authors><pubmed_authors>Hurlbut DJ</pubmed_authors><pubmed_authors>Guzman-Rodriguez M</pubmed_authors><pubmed_authors>Allen-Vercoe E</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Martz SL</pubmed_authors><pubmed_authors>Petrof EO</pubmed_authors></additional><is_claimable>false</is_claimable><name>A human gut ecosystem protects against C. difficile disease by targeting TcdA.</name><description>&lt;h4>Background&lt;/h4>A defined Microbial Ecosystem Therapeutic (MET-1, or "RePOOPulate") derived from the feces of a healthy volunteer can cure recurrent C. difficile infection (rCDI) in humans. The mechanisms of action whereby healthy microbiota protect against rCDI remain unclear. Since C. difficile toxins are largely responsible for the disease pathology of CDI, we hypothesized that MET-1 exerts its protective effects by inhibiting the effects of these toxins on the host.&lt;h4>Methods&lt;/h4>A combination of in vivo (antibiotic-associated mouse model of C. difficile colitis, mouse ileal loop model) and in vitro models (FITC-phalloidin staining, F actin Western blots and apoptosis assay in Caco2 cells, transepithelial electrical resistance measurements in T84 cells) were employed.&lt;h4>Results&lt;/h</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Apr</publication><modification>2025-04-19T00:00:03.972Z</modification><creation>2019-03-26T23:22:02Z</creation></dates><accession>S-EPMC5177537</accession><cross_references><pubmed>27329502</pubmed><doi>10.1007/s00535-016-1232-y</doi></cross_references></HashMap>